出典:Wikipedia
出典:『Wikipedia』 (2011/05/06 13:18 UTC 版)
Laropiprant (INN) is used in combination with niacin to reduce blood cholesterol (LDL and VLDL). Merck & Co. planned to market this combination under the trade names Cordaptive and Tredaptive. On April 28, 2008, the U.S. Food and Drug Administration (FDA) issued a "not approved" letter for Cordaptive. Tredaptive was approved by the European Medicines Agency (EMA) on July 3, 2008.
| ・laropiprant | |
| ・cobet | |
| ・Different than | |
| ・Ly114 | |
| ・based boys | |
| ・picket pool | |
| ・cintamani | |
| ・mor218-7 | |
| ・xg | |
| ・EVG1 |